- Home
- AGCC vs EBS Comparison
AGCC vs EBS Comparison
Compare AGCC & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGCC | EBS |
|---|---|---|
| Founded | 2020 | 1998 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.4M | 413.3M |
| IPO Year | 2025 | 2006 |
Fundamental Metrics
Financial Performance| Metric | AGCC | EBS |
|---|---|---|
| Price | $14.63 | $5.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 61.8K | ★ 1.3M |
| Earning Date | 05-23-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 125.83 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $168.97 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.23 | $4.36 |
| 52 Week High | $25.73 | $14.06 |
Technical Indicators
Market Signals| Indicator | AGCC | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 34.67 |
| Support Level | $14.18 | $4.36 |
| Resistance Level | $16.00 | $8.73 |
| Average True Range (ATR) | 0.43 | 0.33 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 43.70 | 21.11 |
Price Performance
Historical ComparisonAbout AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares
Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.